Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the first patient in Cohort 4 of its ...

Data in and of itself can be interesting, but the true value of data lies in how you use it and the insights that come from ...

vTv Therapeutics, a biopharmaceutical company based in High Point, has received clearance from the U.S. Food and Drug ...

Punjab Agricultural University (PAU) will soon undertake the second round of field trials for pink bollworm-resistant (PBW) ...

Lantern is a leader in the development of tech-bio to deliver the next generation of cancer medicines, where success is defined by both AI-driven progress and meaningful patient outcomes," said Panna ...

Recent innovations in evidence based medicine methods, in particular instruments assessing risk of bias in randomised trials, have focused on methodological rigour at the expense of simplicity and ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...

Lipocine has announced the commencement of a Phase III clinical trial of LPCN 1154, being developed for postpartum depression ...

Berubicin showed clinically relevant outcomes comparable to Lomustine across multiple endpoints, but not a statistically ...

ICMR invites EoI for joint development & commercialization of typhoid & paratyphoid vaccine: Shardul Nautiyal, Mumbai Wednesday, March 26, 2025, 08:00 Hrs [IST] The Indian Council ...